ORTHIC Book a 20-minute call

Revised Schedule M · for pharma manufacturers

Get your plant ready for revised Schedule M.

Orthic is quality infrastructure for Indian pharma. We show you where your plant stands against revised Schedule M, close the gaps alongside your QA team, and keep the evidence inspection-ready.

Not ready for a call? Take the free 10-question Schedule M check. Five minutes, no sign-up.

Starting with manufacturers in Baddi, then Gujarat and Maharashtra.

Gap report · excerptIllustrative format
Pharmaceutical quality systemNo documented management review; quality objectives not setHigh
Qualification and validationHVAC requalification overdue; no validation master planHigh
Computerised systemsShared logins on lab software; audit trails never reviewedHigh
Product quality reviewAnnual review not done for every productMedium
DocumentationBatch record corrections made without a reason recordedMedium
An example of the format, not a client finding. Client reports are confidential.

Why now

Revised Schedule M applies to MSME plants today.

Revised Schedule M raised the GMP bar for every licensed manufacturer. Small and medium manufacturers, with turnover up to ₹250 crore, that filed an upgrade plan were given until 31 December 2025. That date has passed.

  • A documented pharmaceutical quality system and quality risk management
  • Qualification and validation of equipment, processes and utilities
  • Product quality reviews at least once a year
  • Controlled computerised systems: every change to a record logged, with backups and access control

Many gaps aren’t about new machines. They sit in documents, records and habits, and most can be found in a diagnostic and planned into a Sprint.

  1. 28 Dec 2023Revised Schedule M notifiedApplies to every licensed manufacturer
  2. 28 Jun 2024Deadline for larger manufacturersTurnover above ₹250 crore
  3. 31 Dec 2025Extended deadline for MSMEsFor those that filed an upgrade plan in Form A
  4. TodayThe requirements apply to MSME plantsPlants without an extension had until 28 Dec 2024

Source: Ministry of Health and Family Welfare, PIB release, February 2025.

Offers

Find the gaps, close them, keep the evidence.

Most plants start with a diagnostic. It tells you what is missing and what it will take, before you commit to anything bigger.

Start here

Schedule M gap diagnostic

Fixed feeagreed upfront

An assessment of your plant and its records against revised Schedule M. You get a confidential report with every finding ranked by risk, and a costed plan to close them.

The full fee is credited if you continue with us.

Book a diagnostic call
Then

Remediation Sprint

Scopedto your plant

A planned programme to close the gaps from the diagnostic, working alongside your QA team until the evidence is in place.

A written progress update every week.

Talk about a Sprint
Keep it running

Orthic software, Starter

Annuallicence

One place for CAPAs, evidence and document control. Every entry goes into a tamper-evident audit trail, so you can show who changed what, and when.

Licensed per facility.

Ask for a demo

We don’t promise inspection outcomes or certification. That decision always rests with the regulator. We help you close the gaps and keep the evidence.

How it works

From a 20-minute call to a plan you can act on.

  1. 01

    A 20-minute call

    We learn about your plant and what prompted you to get in touch, and you decide whether a diagnostic makes sense.

  2. 02

    A confidential assessment

    A fixed fee and scope in writing and a mutual NDA, then an assessment of your plant and its records against revised Schedule M.

  3. 03

    Your report and plan

    Within 10 working days: a confidential report ranked by risk, walked through with your team. If you continue with us, the fee is credited in full.

Who we work with

Plants that want a clear plan.

  • Formulation manufacturers with turnover up to ₹250 crore
  • Plants that have received an inspection observation, an NSQ report or a licensing query
  • Brand owners who want their contract manufacturers checked against revised Schedule M

About

Founder-led, based in Mumbai.

Arjun Akshikar
Founder

Arjun grew up between Mumbai, Lagos, Istanbul and Madison and studied economics and political science at the University of Wisconsin–Madison. He started Orthic in 2026 to bring small and mid-sized pharma manufacturers the structured quality work that large companies get from in-house teams.

We are building a small team of experienced QA practitioners and engineers to work alongside plant teams.

Questions

What plant teams ask first.

Will this guarantee we pass an inspection?

No. Nobody can honestly promise that. We find the gaps, help you close them and keep the evidence ready for the inspector.

Do you replace our QA team?

No. We work alongside them, and the SOPs and records we help write stay yours.

Is our data safe?

We sign a mutual NDA before we see any document. Orthic software records every change in a tamper-evident audit trail, so you can see who changed what, and when.

Does the diagnostic fee go to waste if we don’t continue?

No. You keep the gap report and the plan. If you continue, the fee is credited to the Sprint.

Contact

Talk to us about your plant.

Tell us where the plant is, what you make and what prompted you to get in touch. Arjun replies within one working day.

Email to book a 20-minute call Not ready to talk? Take the free readiness check
Or write toarjun@orthichq.com

Useful to include: plant location, dosage forms, your role, and any recent inspection observation or NSQ report.

Email to book a 20-minute call